Lidan Bai Selected Research

Anorexia

12/2020

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lidan Bai Research Topics

Disease

2	Neoplasms (Cancer) 12/2023 - 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Fatigue 02/2023
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 12/2020
1	Febrile Neutropenia 12/2020
1	Esophageal Squamous Cell Carcinoma 12/2020
1	Anorexia 12/2020
1	Leukopenia 12/2020
1	Neutropenia 12/2020

Drug/Important Bio-Agent (IBA)

1	Circular RNAIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	LuciferasesIBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Polysaccharides (Glycans)IBA 02/2023
1	AntioxidantsIBA 02/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	camrelizumabIBA 12/2020
1	nedaplatinIBA 12/2020
1	apatinibIBA 12/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	BilirubinIBA 12/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2020